National Research Programs
Did you know that every major advance in the fight against breast cancer has been touched by Susan G. Komen®? That we’ve provided more money for breast cancer research and community health programs than any entity besides the U.S. government? Komen’s goal is to “energize science to find the cures.”
Komen’s commitment to supporting life-saving research has never been stronger. Building on 27 years of funding research to find the causes and cures of breast cancer, Komen continues its important new focus on research that will speed the translation of discoveries into reductions in breast cancer mortality and/or incidence within the next decade and on addressing disparities in breast cancer across populations.
A percentage of the net income from each Affiliate supports the Komen Research, Evaluation and Scientific Program, which funds groundbreaking breast cancer research, meritorious awards and educational and scientific conferences around the world.
Information about National Research Programs
We have made a promise to end breast cancer forever – energizing science to find the cures is a critical part of this promise. Click here to read more about some that are fulfilling this promise.
The first Susan G. Komen research grant in Michigan was awarded in 1995. Since then, Michigan has seen 84 total research grants and a total of over $28,250,000 in funding within the state of Michigan.
Currently there are 6 active grants funded by Susan G. Komen totaling over $3,780,000. The programs are as follows:
- Triple Negative Breast Cancer in Women with African Ancestry by Dr. Lisa Ann Newman
- Uncovering Mechanisms Responsible for Shoulder Morbidity Following Radiotherapy by Dr. David Lipps, Dr. Jonathan Strauss, and Dr. Eric Perreault
- Multidisciplinary Training in the Biology of Breast Cancer Disparities
- Role of Cancer Stem Cells in Mediating Resistance to DNA Repair Targeting Therapy by Monika Burness and Max Wicha
- Novel Devices to Capture Circulating Tumor Cells by Dr. Daniel Hayes
- Breast Cancer Cell Sensitivity to Radiotherapy in the Presence of Targeted Therapies by Dr. Lori Pierce
For more detailed research information, please visit the Susan G. Komen Research page here.